Sign up to save your podcasts
Or
Share The First $100 Billion Drug
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The First $100 Billion Drug
BofA analyst Geoff Meacham talks about downgrading Pfizer, upgrading Merck, and what he thinks will become the best selling medicine of all time.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Barron's
4.7
15081,508 ratings
BofA analyst Geoff Meacham talks about downgrading Pfizer, upgrading Merck, and what he thinks will become the best selling medicine of all time.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Barron's Streetwise
View all
Motley Fool Hidden Gems Investing
3,223 Listeners
WSJ Your Money Briefing
1,713 Listeners
Investing Insights
521 Listeners
Exchanges
974 Listeners
WSJ What’s News
4,363 Listeners
Masters in Business
2,184 Listeners
WSJ Minute Briefing
684 Listeners
Wall Street Breakfast
1,037 Listeners
Numbers by Barron's
377 Listeners
The Readback
212 Listeners
The Long View
938 Listeners
Thoughts on the Market
1,311 Listeners
Barron's Advisor
113 Listeners
Barron's Live
210 Listeners
Investing Experts
72 Listeners
The Markets
77 Listeners
WSJ's Take On the Week
142 Listeners
At Barron's
20 Listeners
The Morning Filter
49 Listeners